ADVERSE EVENTS IN PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS <25 OR <15 MG/DL ON AT LEAST TWO CONSECUTIVE VISITS IN FOURTEEN RANDOMIZED, CONTROLLED, CLINICAL TRIALS OF ALIROCUMAB
Overview of attention for article published in JACC, March 2015
Altmetric Badge
About this Attention Score
-
Average Attention Score compared to outputs of the same age
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 15 Mendeley